Press Release SolarEdge Acquires Wevo Energy, EV Charging Optimization and Management Software Startup 4 April 2024
Press Release Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer 4 April 2024
Press Release AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE 4 April 2024
Press Release MercuryGate Named as a Challenger in the 2024 Gartner® Magic Quadrant™ for Transportation Management Systems 4 April 2024
